NEUWAY Pharma

NEUWAY Pharma is developing a novel biotherapeutic drug built around its proprietary Engineered Protein Capsule (EnPC®), which can cross the blood-brain barrier and deliver transformative neuro-pharmaceuticals for the treatment of central nervous system (CNS) diseases. The company aims to become the preferred partner for antibody and mRNA drug developers who need to overcome current obstacles in delivering these and other drug modalities to the brain and central nervous tissue.